← Leaderboards
Gerald D. Weinstein
University Of California San Diego
$29,603
Attributed
$29,603
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $27.2K · FY2005–09$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$29,603 · 5
By mechanism
M01$29,603 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Gerry R Boss$29,163,355
- Deborah Hye Spector$13,137,426
Others in their field
Top investigators on “Chronic”
- Judith S. Currier · University Of California Los Angeles$245,012,139
- Lawrence Corey · Fred Hutchinson Cancer Center$209,947,290
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$201,828,077
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$173,476,538
- John M Lachin · George Washington University$125,152,883
- David M Nathan · Massachusetts Institute Of Technology$120,438,756
Research focus
ChronicGrantFundingUnited States National Institutes Of HealthComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionResourcesResearch PersonnelSourceChronic Small Plaque PsoriasisPsoriasisClinical ResearchPharmaceutical PreparationsSkinDouble-Blind MethodDoseClindamycinCyclosporine/MethotrexateCutaneousAnthralinGeneticGeneral PopulationEuropeComparative Efficacy
Grant awards (5)
EFFECTS OF PRK 124 (0125%) LOTION IN ACNE ROSACEA$26,611
M01 · FY2009 · RR · contact PI
M06-890: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED ST$566
M01 · FY2009 · RR · contact PI
A MULTICENTER OPEN-LABEL CONTINUATION STUDY IN MODERATE TO SEVERE CHRONIC PLA$69
M01 · FY2008 · RR · contact PI
A MULTICENTRE, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED PHASE III STUDY OF$525
M01 · FY2006 · RR · contact PI
ALEFACEPT C-740$1,832
M01 · FY2005 · RR